The Evolving Field of Acute Coronary Syndrome Management: A Critical Appraisal of the 2023 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndrome

Acute coronary syndromes (ACS), encompassing conditions like ST-elevation myocar-
dial infarction (STEMI) and non-ST-elevation acute coronary syndromes (NSTE-ACS), represent a
significant challenge in cardiovascular care due to their complex pathophysiology and substantial
impact on morbidity and mortality. The 2023 European Society of Cardiology (ESC) guidelines
for ACS management introduce several updates in key areas such as invasive treatment timing
in NSTE-ACS, pre-treatment strategies, approaches to multivessel disease, and the use of imaging
modalities including computed tomography (CT) coronary angiography, magnetic resonance imaging
(MRI), and intracoronary imaging techniques, such as optical coherence tomography (OCT) and
intravascular ultrasound (IVUS). They also address a modulation of antiplatelet therapy, taking
into consideration different patient risk profiles, and introduce new recommendations for low-dose
colchicine. These guidelines provide important evidence-based updates in practice, reflecting an
evolution in the understanding and management of ACS, yet some potentially missed opportunities
for more personalized care and technology adoption are discussed.